SEBI Reg. Investment Advisor

Download App
Help Center Subscribe
Money Works 4 Me Logo MoneyWorks4Me
Talk to Advisor
Login Get Free Account
Sign Up

MoneyWorks4Me

Log In Sign Up Schedule Free 15‑min Call
Login Get Free Account
Sign Up

National Peroxide Ltd (544205)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 544205 NSE: Chemicals | Small Cap | National Peroxide Share Price

₹590.55 -2.25 (-0.38%)

As on 03-Jul'26 16:59

National Peroxide Ltd (544205)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 544205 NSE: Chemicals | Small Cap | National Peroxide Share Price

₹590.55 -2.25 (-0.38%)

As on 03-Jul'26 16:59

Key Metrics
Valuation Multiples
Market Cap
₹339 Cr.
Current Price
₹590.6
52-Week Low / High
₹350 / 770
TTM EPS
₹19.2
TTM Sales
₹290 Cr.
Book Value per Share
₹629.9
P/E Ratio
30.75
Higher than its 5-year historical median
Industry PE
52.7
Price to Book (P/B)
0.94
Lower than its 5-year historical median
Price to Sales (P/S)
1.17
In line with its 5-year historical median
EV/EBITDA
8.49
Lower than its 5-year historical median
Dividend Yield
0%
Profitability Efficiency
Return on Equity (ROE)
-0.63%
Underperforms industry median
Return on Capital Employed (ROCE)
-0.11%
Underperforms industry median
Return on Assets (ROA)
-0.49%
Operating Profit Margin
5.7%
Net Profit Margin
-0.78%
Gross Profit Margin
5.7%
Growth Momentum
1-yr vs 3-yr growth
Sales Growth (1 Year)
-
-13.85%
Operating Profit Growth (1 Year)
-
-58.81%
Net Profit Growth (1 Year)
-
-113.4%
Asset Quality
Promoter Holding
70.76%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
₹356 Cr.
Equity
₹5.8 Cr.
Face Value
₹10
All Time Low / High
₹350.00 / 1418.05

National Peroxide stock performance

Key Ratios
mw4me loader

Check Before You Invest

Check Before You Invest

Quality

Locked
Login to view analysis.

Valuation

Locked
Login to view analysis.

Price Trend

Locked
Login to view analysis.
Q.1 Is National Peroxide Ltd a good quality company?
National Peroxide Ltd is a weak quality company, based on a inconsistent multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

View More

We have analysed the performance of the company on the following:

  • How has it performed on generating Profits?

    By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.

  • How efficiently has it utilized Capital?

    By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.

  • How is it managing its Debt?

    By checking its Debt to Equity and Cash Flow from Operations.

View More
How does National Peroxide Ltd performance compare with that of its Peers?
Q.1 Revenue growth of National Peroxide Ltd vs industry peers?
National Peroxide Ltd revenue CAGR is 0.00%, compared to the industry median CAGR of 4.7%, indicating slower growth and losing its market share.
Q.1 Promoter shareholding and pledge status of National Peroxide Ltd?
Promoters hold 70.76% of the National Peroxide Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Q.1 Stock return of National Peroxide Ltd over the last decade?
Over the last 1 year(s), the stock has delivered a CAGR of 3.48% based on the current price.
View More

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
National Peroxide Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation ⓘ

Mar'23Mar'24Mar'25TTM
ROCE % ⓘ16.5%6.4%-0.1%-
Value Creation
Index ⓘ		0.2-0.5-1.0-

Growth Parameters ⓘ
Sales ⓘ377333287290
Sales YoY Gr.--11.7%-13.9%-
Adj EPS ⓘ028.2-319.2
YoY Gr.-NA-110.6%-
BVPS (₹) ⓘ0624.6607.7629.9
Adj Net
Profit ⓘ		28.516.2-1.711
Cash Flow from Ops. ⓘ67.136.418.7-
Debt/CF from Ops. ⓘ0.20.30.4-

CAGR ⓘ

9 Years 5 Years 3 Years 1 Years
Sales ⓘNANANA-13.9%
Adj EPS ⓘNANANA-110.6%
BVPSⓘNANANA-2.7%
Share Price - - - -17.2%

Key Financial Parameters ⓘ

Mar'23Mar'24Mar'25TTM
Return on
Equity % ⓘ		8.14.6-0.53.1
Op. Profit
Mgn % ⓘ		15.811.15.710.8
Net Profit
Mgn % ⓘ		7.64.9-0.63.8
Debt to
Equity ⓘ		0000
Working Cap
Days ⓘ		0829577
Cash Conv.
Cycle ⓘ		0334054

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'23Mar'24Mar'25
Sales377333287
Operating Expenses ⓘ + 317296272
Manufacturing Costs687267
Material Costs181161148
Employee Cost 262930
Other Costs ⓘ 423526
Operating Profit ⓘ 603715
Operating Profit Margin (%) 15.8%11.1%5.3%
Other Income ⓘ + 864
Exceptional Items ⓘ 1300
Interest ⓘ 722
Depreciation ⓘ 201920
Profit Before Tax ⓘ 5422-2
Tax ⓘ 1450
Profit After Tax 4017-2
PAT Margin (%) 10.5%5.0%-0.8%
Adjusted EPS (₹)0.029.2-3.9
Dividend Payout Ratio (%)0%42.80%0%

Valuation of National Peroxide - Standalone

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Analyst's Notes

data not found
No data found!

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund + 346359349
Share Capital ⓘ 066
Reserves ⓘ 346353344
Debt +1074
Long Term Debt1074
Short Term Debt000
Minority Interest000
Trade Payables232220
Others Liabilities ⓘ 828281
Total Liabilities ⓘ 461470453

Fixed Assets

Net Fixed Assets ⓘ +336321312
Gross Block426431435
Accumulated Depreciation91110123
CWIP ⓘ 3113
Investments ⓘ 403537
Inventories363432
Trade Receivables242723
Cash Equivalents 71724
Others Assets ⓘ 162522
Total Assets ⓘ 461470453

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'23Mar'24Mar'25
Cash Flow From Operating Activity ⓘ + 673619
PBT ⓘ 5422-2
Adjustment ⓘ 231819
Changes in Working Capital ⓘ -245
Tax Paid ⓘ -8-7-3
Cash Flow From Investing Activity ⓘ + 25-18-2
Capex -6-14-4
Net Investments 30-42
Others ⓘ 011
Cash Flow From Financing Activity ⓘ + -86-17-13
Net Proceeds from Shares ⓘ 000
Net Proceeds from Borrowing ⓘ -80-4-4
Interest Paid ⓘ -6-3-2
Dividend Paid ⓘ 0-10-7
Others ⓘ 0-0-0
Net Cash Flow ⓘ 624

Financial Ratio

PARTICULARSMar'23Mar'24Mar'25
Ratios
ROE (%)11.414.76-0.63
ROCE (%)16.546.39-0.11
Asset Turnover Ratio0.880.780.68
PAT to CFO Conversion(x)1.682.12N/A
Working Capital Days
Receivable Days21.902629
Inventory Days32.7035.4038.50
Payable Days46.5051.5051.90

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

National Peroxide Ltd FAQs

The current trading price of National Peroxide on 03-Jul-2026 16:59 is ₹590.5.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 02-Jul-2026 the market cap of National Peroxide stood at ₹339.4 Cr

The latest P/E ratio of National Peroxide as of 02-Jul-2026 is 30.75.

The latest P/B ratio of National Peroxide as of 02-Jul-2026 is 0.94.

The 52-week high of National Peroxide is ₹770.0 and the 52-week low is ₹350.0.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of National Peroxide is ₹290 ( Cr.) .

Past 10 year’s financial track record analysis by Moneyworks4me indicates that National Peroxide Ltd is a below average quality company.

The key valuation ratios of National Peroxide Ltd's currently when compared to its past seem to suggest it is in the Fair zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of National Peroxide Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

About National Peroxide Ltd

National Peroxide (NPL) is a public limited Company established in 1954. It is also certified for ISO 9001 Quality Management System, ISO 14001 Environmental Management System, ISO 45001 Occupational Health & Safety Management System, RC - 14001 Responsible Care System and ISO-50001 Energy Management System. The company is also certified for the Prestigious Responsible care Logo by Indian Chemical Council, an apex body in India for implementation of Responsible Care in all industries.

The company is a pioneer in India for peroxygen chemicals and is the largest manufacturer of Hydrogen Peroxide in India. It's fully integrated manufacturing site for Hydrogen Peroxide is located at Kalyan in Maharashtra (India). NPL’s Hydrogen Peroxide is a concentrated aqueous solution containing 50% Hydrogen Peroxide by weight and is commonly referred to as Hydrogen Peroxide 50% w/w. It is specially stabilised for Indian climatic conditions. It also produces Hydrogen Peroxide in 35%, 60% and 70% concentration.

Business area of the company

The company is in the business of peroxide chemicals and is the largest manufacturer of Hydrogen Peroxide in India. Besides Hydrogen Peroxide, the company also manufactures Compressed Hydrogen Gas and Peracetic Acid.

Products of the company

  • Hydrogen peroxide
  • Compressed hydrogen gas
  • Peracetic acid

To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
2026 ©The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me® is a registered trademark of The Alchemists Ark Pvt. Ltd.

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: